PATENT CLAIM ANALYSIS

Application Number: 16109127
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "020500"]

Abstract:
The invention provides pharmaceutical compositions comprising about 0.05 to 0.1% (w/v) cyclosporine dissolved in 1-perfluorobutyl-pentane for use in the topical treatment of dry eye disease and provides for dosing and treatment methods thereof. The invention further provides kits comprising such compositions.

Claim (Index 33):
The method according to  claim 32 , wherein the composition consists of about 0.1% (w/v) cyclosporine dissolved in 1-perfluorobutyl-pentane and about 1.0% (w/w) of ethanol.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 96.0
- Lexical Diversity: 1.31429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15142709', '15676968', '12685510', '13601258', '15742867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7690017580672012
- 35 USC 102 Novelty (BERT): 0.5163599407199437
- Combined Prediction Score: 0.7437375763324754
- Mean Citation Score: 251.82278
- Max Citation Score: 280.8045
- Similarity Product: 182.4607394121588

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test